SCM
DERM icon

Sterling Capital Management’s Journey Medical DERM Stock Holding History

Sterling Capital Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$628 Buy
134
+54
+68% +$419 ﹤0.01% 3132
2025
Q4 		$617 Buy
80
+50
+167% +$392 ﹤0.01% 3178
2025
Q3 		$214 Buy
30
+1
+3% +$7 ﹤0.01% 3210
2025
Q2 		$208 Buy
+29
New +$200 ﹤0.01% 3231

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sterling Capital Management's DERM Position: Q1 2026 in Review

Sterling Capital Management increased its Journey Medical (DERM) stake by 68% in Q1 2026, buying an estimated $419 and bringing the position to 134 shares worth $628. The position accounts for ﹤0.01% of the portfolio, ranked #3132.

Sterling Capital Management first reported a position in DERM in Q2 2025 and has held it in 4 quarters since. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Sterling Capital Management held 134 shares of Journey Medical worth $628 as of Q1 2026.
  • Sterling Capital Management bought 54 Journey Medical shares in Q1 2026, an estimated $419.
  • Journey Medical made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #3132 holding.
  • Sterling Capital Management first reported a position in Journey Medical in Q2 2025 and has held it in 4 quarters since.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.